Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

From Rational Design of Drug Crystals to Understanding of Nucleic Acid Structures: Lamivudine Duplex

Texto completo
Autor(es):
Martins, Felipe T. [1] ; Doriguetto, Antonio C. [2] ; Ellena, Javier [1]
Número total de Autores: 3
Afiliação do(s) autor(es):
[1] Univ Sao Paulo, Inst Fis Sao Carlos, BR-13560970 Sao Carlos, SP - Brazil
[2] Univ Fed Alfenas, Dept Ciencias Exatas, BR-37130000 Alfenas, MG - Brazil
Número total de Afiliações: 2
Tipo de documento: Artigo Científico
Fonte: Crystal Growth & Design; v. 10, n. 2, p. 676-684, FEB 2010.
Citações Web of Science: 21
Resumo

A DNA-like duplex of nucleosides is probable to exist even without the 5'-phosphate groups needed to assemble the chain backbone. However, double-stranded helical structures of nucleosides are unknown. Here, we report a duplex of nucleoside analogs that is spontaneously assembled due to stacking of the neutral and protonated molecules of lamivudine, a nucleoside reverse transcriptase inhibitor (NTRI) widely used in anti-HIV drug combinatory medication. The left-handed lamivudine duplex has features similar to those of i-motif DNA, as the face-to-face base stacking and the helix rise per base pair. Furthermore, the protonation pattern on alternate bases expected for it DNA-like duplex stabilized by pairing of neutral and protonated cytosine fragments was observed for the first time in the lamivudine double-stranded helix. This structure demonstrates that hydrogen bonds can substitute for covalent phosphodiester linkage in the stabilization of the duplex backbone. This interesting example of spontaneous molecular self-organization indicates that the 5'-phosphate group could not be a requirement for duplex assembly. (AU)

Processo FAPESP: 07/07185-5 - Obtenção, caracterização e avaliação de novas formas cristalinas de fármacos antiretrovirais e antineoplásicos
Beneficiário:Felipe Terra Martins
Modalidade de apoio: Bolsas no Brasil - Doutorado